Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
6,223,539
-
Shares change
-
+101,107
-
Total reported value, excl. options
-
$39,457,000
-
Value change
-
+$656,982
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$6.34
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q3 2020
12 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q3 2020.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,223,539 shares
of 27,615,000 outstanding shares and own 22.54% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,313,489 shares), Johnson & Johnson Innovation - JJDC, Inc. (2,133,402 shares), MMCAP International Inc. SPC (684,451 shares), RTW INVESTMENTS, LP (600,000 shares), MILLENNIUM MANAGEMENT LLC (415,296 shares), Taylor Wealth Management Partners (43,552 shares), LMR Partners LLP (29,039 shares), UBS Group AG (2,236 shares), BlackRock Inc. (2,074 shares), and BESSEMER GROUP INC (0 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.